Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases
- 1 January 2004
- journal article
- review article
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 385 (11) , 1035-9
- https://doi.org/10.1515/bc.2004.134
Abstract
Aspartic proteases have emerged as targets for substrate-based inhibitor design due to their vital roles in the life cycles of the organisms that cause AIDS, malaria, leukemia, and other infectious diseases. Based on the concept of mimicking the substrate transition-state, we designed and synthesized a novel class of aspartic protease inhibitors containing the hydroxymethylcarbonyl (HMC) isostere. An unnatural amino acid, allophenylnorstatine [Apns; (2 S ,3 S )-3-amino-2-hydroxy-4-phenylbutyric acid], was incorporated at the P1 site in a series of peptidomimetic compounds that mimic the natural substrates of the HIV, HTLV-I, and malarial aspartic proteases. From extensive structure-activity relationship studies, we were able to identify a series of highly potent peptidomimetic inhibitors of HIV protease. One highly potent inhibitor of the malarial aspartic protease (plasmepsin II) was identified. Finally, a promising lead compound against the HTLV-I protease was identified.Keywords
This publication has 16 references indexed in Scilit:
- A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV‐1 proteaseProteins-Structure Function and Bioinformatics, 2004
- Structure–activity and structure–metabolism relationships of HIV protease inhibitors containing the 3-hydroxy-2-methylbenzoyl-allophenylnorstatine structureBioorganic & Medicinal Chemistry, 2004
- High-Affinity Inhibition of a Family of Plasmodium falciparum Proteases by a Designed Adaptive InhibitorBiochemistry, 2003
- Effects of nucleoside-based antiretroviral chemotherapy on human T cell leukaemia/lymphotropic virus type 1 (HTLV-1) infection in vitroJournal of Antimicrobial Chemotherapy, 2003
- Protease Inhibitors: Design and New FeaturesKagaku to Seibutsu, 2003
- HIV Protease Inhibitors: Peptidomimetic Drugs and Future PerspectivesCurrent Medicinal Chemistry, 2002
- Anisotropic Dynamics of the JE-2147−HIV Protease Complex: Drug Resistance and Thermodynamic Binding Mode Examined in a 1.09 Å Structure,Biochemistry, 2002
- Structure−Activity Relationship of Small-Sized HIV Protease Inhibitors Containing AllophenylnorstatineJournal of Medicinal Chemistry, 1999
- Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimicBiopolymers, 1999
- Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostereBiopolymers, 1996